<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04445857</url>
  </required_header>
  <id_info>
    <org_study_id>IRB 6379</org_study_id>
    <nct_id>NCT04445857</nct_id>
  </id_info>
  <brief_title>Efficacy of Coadministration of Calcitonin and Hyperbaric Bupivacaine on Spinal Anesthesia in Tramadol-abuse Patients</brief_title>
  <official_title>Efficacy of Coadministration of Calcitonin and Hyperbaric Bupivacaine on Spinal Anesthesia in Lower Abdominal and Limb Surgeries in Tramadol-abuse Patients: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Increasing duration of local anesthetic action is desired for prolongation of postoperative&#xD;
      patient comfort, as well as decreasing perioperative opioid consumption and subsequent side&#xD;
      effects. Calcitonin, discovered in 1961, has been established, synthesized, and developed for&#xD;
      use in treating disease. In 1983 it was demonstrated that calcitonin is an analgesic, which&#xD;
      is also effective in the epidural and subarachnoid spaces.Tramadol abuse has dramatically&#xD;
      increased in Egypt since 2008 and has led to many admissions to addiction treatment&#xD;
      centers.It was shown that the duration of sensory block of spinal anesthesia with hyperbaric&#xD;
      bupivacaine in chronic opium abusers undergoing lower extremity orthopedic surgery was much&#xD;
      shorter in chronic opium abusers compared with non-abusers.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2020</start_date>
  <completion_date type="Actual">January 31, 2021</completion_date>
  <primary_completion_date type="Actual">January 31, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The length of the sensory block (min) of spinal anesthesia in tramadol-abuse patients intrathecally or i.v.</measure>
    <time_frame>procedure</time_frame>
    <description>The length of the sensory block (min) of spinal anesthesia in tramadol-abuse patients intrathecally or i.v.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Analgesia</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>injection of 15 mg (2.5 ml) hyperbaric bupivacaine 0.5% and 100 IU salmon calcitonin(1ml) intrathecally and injection of 10 ml normal saline (NS) slowly intravenously (IV) over 5 min.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>injection of 15 mg (2.5 ml) hyperbaric bupivacaine 0.5% and 1ml NS intrathecally and injection of 100 IU salmon calcitonin (1ml) diluted in 9 ml NS slowly IV over 5 min.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3 (control group)</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>injection of 15 mg (2.5 ml) hyperbaric bupivacaine 0.5% and 1ml NS intrathecally and injection of 10 ml NS slowly IV over 5 min.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Calcitonin presented as MiacalcicÂ® ampoules 100 IU/ml (1ml)</intervention_name>
    <description>coadministration of calcitonin and a single-shot hyperbaric bupivacaine prolongs the length of the sensory block (min) of SA in tramadol-abuse patients independent of the route of calcitonin administration intrathecally or i.v.</description>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_label>Group 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>normal saline (NS)</intervention_name>
    <description>1ml NS intrathecally OR injection of 10 ml NS slowly IV over 5 min.</description>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_label>Group 2</arm_group_label>
    <arm_group_label>Group 3 (control group)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with history of substance use disorders (SUD) history of tramadol addiction&#xD;
             (single drug addiction and substances used besides tramadol) and duration of addiction&#xD;
             &gt;1 year&#xD;
&#xD;
          -  Elective lower abdomen or lower extremities surgeries under spinal anesthesia&#xD;
&#xD;
          -  ASA physical status I and II&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient's refusal,&#xD;
&#xD;
          -  duration of surgery more than 120 min,&#xD;
&#xD;
          -  obesity with body mass index (BMI) &gt;35 kg/m2,&#xD;
&#xD;
          -  generalized infection or localized infection at level of blockade,&#xD;
&#xD;
          -  neurological disease,&#xD;
&#xD;
          -  psychological disorder&#xD;
&#xD;
          -  coagulation disorder,&#xD;
&#xD;
          -  history of uncontrolled hypertension,&#xD;
&#xD;
          -  history of uncontrolled blood sugar,&#xD;
&#xD;
          -  allergy to bupivacaine or calcitonin&#xD;
&#xD;
          -  or failed spinal.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ibrahim Mamdouh Esmat</name>
      <address>
        <city>Cairo</city>
        <state>Married</state>
        <zip>11361</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>June 21, 2020</study_first_submitted>
  <study_first_submitted_qc>June 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 24, 2020</study_first_posted>
  <last_update_submitted>May 26, 2021</last_update_submitted>
  <last_update_submitted_qc>May 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Dr.Ibrahim Mamdouh Esmat</investigator_full_name>
    <investigator_title>Assistant Professor of Anesthesia and Intensive Care Department, Faculty of Medicine, Ain- shams University, Cairo, Egypt.</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcitonin</mesh_term>
    <mesh_term>Salmon calcitonin</mesh_term>
    <mesh_term>Calcitonin Gene-Related Peptide</mesh_term>
    <mesh_term>Katacalcin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

